Back to search

Article

Polygenic Risk for Skin Autoimmunity Impacts Immune Checkpoint Blockade in Bladder Cancer

2019-12-19

Abstract excerpt

PD-1 and PD-L1 act to restrict T-cell responses in cancer and contribute to self-tolerance. Consistent with this role, PD-1 checkpoint inhibitors have been associated with immune-related adverse events (irAEs), immune toxicities thought to be autoimmune in origin. Analyses of dermatological irAEs have identified an association with improved overall survival (OS) following anti-PD-(L)1 therapy, but the factors that...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
19b1b250-85ac-53a6-98ae-4bd753acb774
DOI
10.1101/2019.12.18.881805
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Polygenic Risk for Skin Autoimmunity Impacts Immune Checkpoint Blockade in Bladder CancerDOI 10.1101/2019.12.18.881805
Select a neighboring publication to make it the new centre.